FDA opens US to Lyrica generics

24-07-2019

Sarah Morgan

FDA opens US to Lyrica generics

Margaret M Stewart / Shutterstock.com

The US Food and Drug Administration (FDA) last week approved nine applications for the first generic versions of Pfizer’s Lyrica (pregabalin).


Pfizer, US Food and Drug Administration, FDA, Lyrica, pregabalin, patent extension, market exclusivity, paediatric exclusivity, patent expiry, generics

LSIPR